Award recordCONTRACT

AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

PIID 36E79719N0017· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $100,295 net obligations· UEI LVEBAQTPN615· NY

Description

DEOLBIGATE FUNDS ON THE TASK ORDER FOR IBUPROFEN FOR THE PHARMACEUTICAL REPACKAGING PROGRAM. I PACKAGED WAS DAMAGED AND RETURNED.

Base award description: TASK ORDER FOR BULK PHARMACEUTICAL REPACKAGING PROGRAM

First action · last action
2019-01-07 · 2019-09-16
Transactions
2
First transaction's obligation
$100,500
Base + all options value (sum of deltas)
$100,295
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P17A0001
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$100,500$0Base award · 2019-01-07 · this action $100,500 · running total $100,500Modification P00001 · 2019-09-16 · this action -$205 · running total $100,295
  • Base2019-01-07+$100,500= $100,500
  • Mod P000012019-09-16-$205= $100,295
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-01-07+$100,500$100,500TASK ORDER FOR BULK PHARMACEUTICAL REPACKAGING PROGRAM
Mod P00001· FUNDING ONLY ACTION2019-09-16−$205$100,295DEOLBIGATE FUNDS ON THE TASK ORDER FOR IBUPROFEN FOR THE PHARMACEUTICAL REPACKAGING PROGRAM. I PACKAGED WAS DA…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LVEBAQTPN615)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0013NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0059260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$319,399FY2026
36C26025F0044260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$173,089FY2025
36C26024F0050260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$185,400FY2024
36E79724A0001NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36F79722D0161NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36E79719N0017_3600_VA797P17A0001_3600 · retrieved 2026-09-26.